UBR7 抗体 (AA 1-50)
Quick Overview for UBR7 抗体 (AA 1-50) (ABIN2576471)
抗原
See all UBR7 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-50
- 
                                            品牌
- IHC-plus™
- 
                                            特异性
- Region between residue 1 to 50 of human Ubiquitin Protein Ligase E3 component N-Recognin 7 using the numbering given in entry NP_786924.2 (GeneID 55148).
- 
                                            纯化方法
- Immunoaffinity purified
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: IHC, IHC-P (5 μg/mL), IP (2 - 10 μg/mg lysate), WB (1:2000 - 1:10000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Tris-citrate/phosphate buffer, pH 7-8, 0.09 % sodium azide.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- 4 °C
- 
                                            储存方法
- Store at 2-8°C for up to 1 year.
- 
                                            有效期
- 12 months
 
- 
                                            
- 
    - UBR7 (Ubiquitin Protein Ligase E3 Component N-Recognin 7 (UBR7))
- 
                                            别名
- UBR7 / C14orf130
- 
                                            背景
- 
                        Name/Gene ID: UBR7
 Synonyms: UBR7, C14orf130, N-recognin-7
- 
                                            基因ID
- 55148
 抗原
- 
                    
 
                                     
                                     
                                    